Glaukos® iStent Infinite Trabecular Micro-Bypass System in Subjects With Mild to Moderate Primary Open-angle Glaucoma - Trial NCT06057051
Access comprehensive clinical trial information for NCT06057051 through Pure Global AI's free database. This phase not specified trial is sponsored by Glaukos Corporation and is currently Recruiting. The study focuses on Glaucoma. Target enrollment is 245 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Glaukos Corporation
Timeline & Enrollment
N/A
Sep 01, 2023
Aug 01, 2027
Primary Outcome
Mean Diurnal Intraocular Pressure (IOP) 12-Month reduction ≥ 20% from Baseline
Summary
Prospective, multicenter, single-arm study of the iStent infinite in adult pseudophakic or
 phakic subjects with mild to moderate primary open angle glaucoma who have not failed
 conventional medical and surgical treatment
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06057051
Device Trial